本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Travere Therapeutics, Inc.

21.46
-0.1800-0.83%
成交量:27.73萬
成交額:597.08萬
市值:19.13億
市盈率:-10.73
高:21.79
開:21.62
低:21.41
收:21.64
52周最高:25.29
52周最低:10.64
股本:8,913.87萬
流通股本:7,928.57萬
量比:0.51
換手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-1.9993
每股收益(LYR):-4.0759
淨資產收益率:-705.73%
總資產收益率:-19.28%
市淨率:58.41
市盈率(LYR):-5.27

資料載入中...

2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/24

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities